Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R (Clone Daclizumab)
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
Applications | FC, IF, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
Applications | ELISA, FC, IHC |
Reactivities | Chimpanzee, Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD64 (Clone H22)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-PD-L1 (Clone 332M7)
Applications | FC |
Reactivities | Human, Monkey, Mouse |
Conjugation | Unconjugated |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |